Niacin and Niacinamide Market Assessment Based on Top Driving Factors during 2019 to 2027

Niacin is an organic compound with chemical formula “C₆H₅NO₂” and is a form of Vitamin B3. U.S. Food and Drug Administration (US FDA) has approved Niacin & Niacinamide to be used in the treatment of patients suffering from pellagra. It is also used to treat a number of diseases such as melanoma, hyperphosphatemia, etc. Usage of Niacin in skin care cosmetics is increasing as it helps in protection of skin cells from UV rays. The global niacin and niacinamide market was valued around 1 Billion in 2018 and is expected to flourish with a CAGR of over 5% in the forecast period of 2019-2027

Key Takeaways from Niacin and Niacinamide Market:

  • Niacin has been a key drug for controlling high cholesterol levels for a long time. However, studies over the past half-decade have shown adverse side-effects associated with Niacin & Niacinamide.
  • According to a study by University of Sydney, Niacinamide has also shown photo-protective effects against melanoma.
  • The chemical is also being used across a number of applications that include animal nutrition, cosmeceuticals, etc.

Animal nutrition application accounted for over half of the market revenue in 2018 as the chemical provides the advantage of limiting various diseases such as Ketosis and other diseases affecting cattle. Developed regions are witnessing a health-consciousness trend that is creating immense opportunities for nutrition dietary supplements such as Niacin and Niacinamide.

The Asia Pacific Excluding Japan (APEJ) Region is expected to rise with the fastest CAGR over the long term forecast period of 2019-2027 due to an increase in diabetics, surging prevalence of metabolic dysfunction, and increasing issues related to overweight & obesity.

Request a Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4290

Product Innovation Focused on Ensuring Lesser Side-Effects

The niacin and niacinamide market is well matured, however it has plenty of room for improvement. Niacin drugs with advanced benefits and lesser side-effects are expected to hit the shelves in the near future. Major players in the market including Jubilant Life Sciences Limited, Lonza Group AG, BASF SE, Koninklijke DSM N.V. are focusing on innovative production launches and acquisitions for increasing their reach in the global niacin and niacinamide market.

More Valuable Insights on Niacin and Niacinamide Market:

Fact.MR, in its new offering, presents an unbiased analysis of the global niacin and niacinamide market, presenting historical demand data (2013-2017) and forecast statistics for the period of 2019-2027. The study divulges essential insights on the niacin and niacinamide market on the basis of form (powder, granular, and liquid) and end-use (human nutrition, pharmaceuticals. animal nutrition, cosmeceuticals, and others) across six major regions.

Ask Industry Professional about Report – https://www.factmr.com/connectus/sample?flag=AE&rep_id=4290

Expert analysis, actionable insights, and strategic recommendations – the Healthcare team at Fact.MR assists clients with unique business intelligence needs on a global level. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the healthcare industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to us to know how we can help.

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact:

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
MARKET ACCESS DMCC Initiative
Email: sales@factmr.com
Web: https://www.factmr.com/

Matched content

Editor’s pick